Home › Funds › Artia Global Partners LP › PROK

Artia Global Partners LP position in PROK

PROKIDNEY CORP · Health Care

Artia Global Partners LP reported holding 1,806,939 shares of PROK (PROKIDNEY CORP) in its Q2 2026 13F filing — a position valued at US$3.7M, representing 0.68% of its reported portfolio and ranking #35 among its reported holdings. Artia Global Partners LP has disclosed PROK holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.81M sh
Reported value held$3.69M
Portfolio Weight0.68%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's PROK position evolved

Artia Global Partners LP first disclosed a stake in PROK in Q4 2025 at 1,838,411 shares (US$4.1M). Across 3 filings, Artia Global Partners LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,806,939 shares valued at US$3.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.84M $4.12M New
Q1 2026 1.81M $3.23M Reduce
Q2 2026 1.81M $3.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PROK and 13F data

PROK (PROKIDNEY CORP) is a Health Care company. 37 other funds we track also report a position in PROK — the largest reported positions include MONTANOVA CAPITAL, LLC (US$25.2M), Bleichroeder LP (US$4.1M), Brown University (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PROK

All PROK fund holders →

FAQ

How long has Artia Global Partners LP held PROK?

Artia Global Partners LP has disclosed PROK holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Artia Global Partners LP's current position in PROK?

As of Q2 2026, Artia Global Partners LP holds 1.81M shares of PROK (PROKIDNEY CORP), valued at $3.69M, representing 0.68% of its reported portfolio and ranking #35.

Has Artia Global Partners LP been buying or selling PROK?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in PROK.

Which other funds hold PROK?

Other major institutional holders of PROK include MONTANOVA CAPITAL, LLC, Bleichroeder LP, Brown University, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.